GLP-3R
GLP-1/GIP/Glucagon Triple Agonist
Research Highlights
Triple receptor co-agonism — GLP-1, GIP, and Glucagon simultaneously
Studied for dose-dependent effects on adipose tissue metabolism in preclinical models
Research models explore tri-agonism vs dual GLP-1/GIP receptor pharmacology
Influences hepatic glucose output, lipid metabolism, and energy expenditure
Lyophilized powder — reconstitution with bacteriostatic water or a suitable solvent is required prior to in-vitro experimental use. BAC Water is available separately in our Solvents category.
Retatrutide is a triple incretin receptor agonist (GIP/GLP-1/glucagon) under research for its metabolic effects, including glycaemic control2 and lipid profile modulation. Its tri-agonism model offers researchers a platform for studying how combined receptor activation influences energy homeostasis1 and adipose tissue metabolism.
Third-Party Verified
Certificates of Analysis
Every batch is independently tested. COAs are issued per lot — all vial sizes from the same lot share one certificate. The batch is tested on a representative sample prior to dispensing.